Home » Argus » Argus Research raised Biogen (NASDAQ:BIIB) price target from $320 to $350 Argus Research raised Biogen (NASDAQ:BIIB) price target from $320 to $350 Posted on May 23, 2023 By legume Argus Research analyst Jasper Hellweg maintains Biogen (NASDAQ:BIIB) with a Buy and raises the price target from $320 to $350. Health Care Tags:Argus, Biogen